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The Upper Respiratory Tract: Mucous
Membrane Irritation
by Rebecca Bascom*
Despite thewidespreadrecognition thatmucosalirritation isacardinalfeatureof"sick-buildingsyndrome,' fewdata
existonthecause, natural history, orpathophysiology ofupperrespiratory mucousmembraneirritation. Thebaseline
prevalenceofnasalsymptomsamongbuildingoccupantsisoften20%,butinsomestudiesitisashighas50to60%. New
techniquesofnasalchallengeandanalysisofcellsandmediatorsinnasallavagefluidhaveprovedusefulintheassessment
ofrhinitiscausedbyantigens, coldair, andviruses, andthesetechniquesarenowbeingappliedtothestudytheresponse
toirritants. Humaninhalationchaflengestudieshaverecentlydemonstratedaspectrumofsensitivity toenvironmental
tobaccosmoke, butthebasisforthisdifferencerequiresadditionalivestigation. Animalandin vio studiesindicate that
thechemosensitive neuronsandairwayepithelium maybecritical targetsforirritantsthatparticipateintheinduction
ofinflaation. Newresearchmethodsareneeded, particularlytoevaluatecomplaintsofnasalcongeston,drying,and
irritation. lbchniqueshouldbedevelopedthatmaybeusefulforfieldstudies,wherethehealtheffectsofacompexmixture
arebeingassessedinaspecificindoorenvironment. Thereexs[tsagroupofindividualswhoreportavarietyofsymptoms
onexposuretolowlevelsofcommonvolatileorganic mixturessuchasperfume,cigarettesmoke,andcleaningagents. Some
oftheseindividuals report havingoccupied "sickbuildings" duringthetimetheirsymptomsbegan. Research isneed-
ed to understand the basisoftheircomplaints, theiretiology, andtreatment.
Introduction
The upperrespiratory tract serves many importantfunctions,
including the warming and humidification of inspired air and
removalofparticleandvapor-phase pollutants. The noseisalso
a major site of common allergic illnesses, the site ofinfection
with common viruses and a site for mucosal irritation and
nonallergic infammation (2). Risk assessment has historically
used excess mortality, cancer, or birth defects as the primary
health effects (3). Theproblemofupperrespiratory tractdisease
is not trivial, since billions of dollars each year are spent to
relieve upperrespiratory symptomsofrhinorrheaandcongestion
(4). Forthe upperrespiratory tract, however, illnessanddiscom-
fortbut notmortality aretheprimaryrecognizedhealtheffects.
Thesehealth risks arehardertoquantify, and newmethodology
may be needed for risk assessment.
The purposeofthis paperis toreviewtheevidencethat upper
respiratory tract mucousmembrane irritation occurs in indoor
environments, to describe research methods available to study
upperrespiratoryeffects, andtoidentifyneedsfor newresearch
methods and gaps in current research.
Clinicalexperienceandepidemiologic studies aretwouseful
sources of information to answer the question: Does mucous
membraneirritation occurinindoorenvironments?Theoriginal
World Health Organization definition of "sick-building syn-
drome" was a consensus ofclinical experience. Thedefinition
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ofsick-building syndrome was irritation ofthe eye, nose, and
throat; dry mucous membranes and skin; erythema; mental
fatigueandheadache; airwayinfectionsandcough; hoarseness
ofthevoiceandwheezing; unspecifichyperreactivity reactions;
andnauseaanddizziness(1). Mucousmembraneirritationhas
continuedtobearecurrentfeatureofindooraircomplaints (5).
The baseline prevalence ofnasal symptoms among building
occupantsvarieswithmanyfactors, includingthepreciseword-
ingofthequestioninthesurvey. Forexample, somesurveysask
about the frequency ofnasal irritation in the past year, while
others ask about the past month, or only the day ofthe study.
Some define "yes" as irritation that is present "often" or "al-
ways," whileotherinvestigators define "yes" asasymptomthat
ispresent "sometimes." Othersurveysdefinework-relatedirrita-
tiononly when symptoms are absentinthe morning andbegin
eachdayafterarrivingatwork. Thisdefinitionmayexcludein-
dividualswithchronicirritationrelatedtotheworkplace. Irrita-
tioncanrefertoasymptomortheinflammationcausedbyanirri-
tant. Asaresultofthesedifferences, cautionmustbeexercised
in comparingprevalenceratesbetween studies.
Thereareagroupofupperrespiratory symptomsthatmayoc-
curafterexposuretoanirritantbutalsomaybecausedbyother
diseases. These symptoms include throat and nose irritation,
nasalcongestion, rhinorrhea(runnynose), postnasaldrip, nasal
drying, sneezing, and hoarseness. Epidemiologic research is
neededtodetermineeffectivemethodsforgroupingthesesymp-
toms. For example, the technique of principal components
analysiscouldsuggestlogicalgroupingsforstatisticalanalysis.
Asabroadgeneralization, ratesofnasalirritation, runnynose,
ornasalcongestionareoftenaround20%, butcanbeashighas
50to60% (5-7).R. BASCOM
Althoughtheexactprevalenceofupperrespiratorymucosalir-
ritationsymptomsmayvary, itisclearthatthereisaspectrumof
symptoms inpopulations thathavebeen studied. Thebasis for
the differential responsiveness is unknown. It is unknown
whethersymptomatic individualsareasensitivesubgroup(i.e.,
reacting at a lower than usual dose, but in a similar manner to
nonsensitiveindividuals)orsensitized (i.e., reacting inaman-
ner that would not occur at any dose in the nonsensitized in-
dividual). It is unknown whether differential responsiveness
results frompreexistingdiseaseoris aninheritedtrait. Itisalso
unknown whether the same distribution ofresponsiveness be-
tween individuals exists forall irritants and irritantmixtures.
Threemajorepidemiologic studiesinthemid-1980sprofiled
health complaints of more than 9000 people and building
characteristicsofmorethan50buildings(8-10). Featuresofthe
buildings, materials, and characteristics of occupants were
relatedtomucosalirritantsymptomprevalence. Inoneormore
studies, symptoms were higher in buildings with a higher oc-
cupancy rate, with use of carbonless copy paper, with high
estimated office surface areas, and with a high fleece factor
(reflecting the presence of a surface onto which irritants or
bioaerosolscouldadsorb). Buildingswithnaturalventilationhad
lower symptom rates than those with mechanical systems that
usedchillersandhumidifiers. Womenhadhighersymptomrates
thanmen, andclerical/secretarialworkershadhigherratesthan
managers. It is unknown whether the higher rates in women
reflect differential reporting ofsimilar health events, different
susceptibility tosimilarexposures, ordifferentexposuresrelated
tojob category orjobperformance.
There are important clinical questions that derive from the
recognitionthat mucousmembraneirritationoccurs in indoor
environments. Physicians need answers to these questions to
assess individual complaints and to advise their patients as to
whethertocontinueworking inabuildingwheresymptomsare
occurring. Thefundamentalquestionis: Doesexposuretocom-
plex mixtures in the indoor environmentalterpeoples' health?
First, what are the long-term consequences of mucous mem-
brane irritation?Second, doesthepresenceofsymptomsofin-
creasedmucousmembraneirritationindicateanincreasedrisk
of inflammation compared with asymptomatic individuals?
Finally, doesincreased inflammationindicateanincreased risk
of organ system damage? The answers to these questions are
largely unknown at present, and practical approaches for the
treatingphysician are lacking.
Astudyofthepathogenesisofmucousmembraneirritationin
indoorenvironments mustfocusonslightlydifferentissues. The
broad research question is: Is there evidence that exposure to
complex mixtures will alter upper respiratory biology or
physiology? More specific questions are: What mixtures are
commonlyfoundinindoorenvironmentsandwhatfactorsdeter-
minetheirritantpropertiesofthesemixtures? Whatpartofthe
upperrespiratory tractisatargetorganforexposuretocomplex
mixtures?Doesdifferentialresponsivenessalterasubject'sdose
of a mixture? How is irritation perceived and how can it be
measured?Whathostfaorsmodulatemucousmembraneirrita-
tion?Whatisthetimecourse, naturalhistory, andsequelaeofan
irritantexposure?Doesincreasedacuteresponsivenessreflectin-
creased riskofchronicdisease?
The following discussion of mucous membrane irritation
details the constituents ofthe nasal mucosa and then presents
results focusing on exposures to three substances: tobacco
smoke, acrolein, andozone. Theseareexamplesofsubstances
for which mucosal responses are thought not to act via an IgE
mechanism. Humanstudies, invitro studies,andanimalstudies
arepresentedthat illustratedifferential responsiveness and in-
dicate target tissues andpossible pathogenetic mechanisms of
irritantresponses. Tobaccosmokeisacomplexmixturethatcon-
tainsboth oxidantsandaldehydes. Acrolein is analdehyde and
isawell-recognized irritant. Ozoneisbothanoutdoorandindoor
air pollutant and is an example ofan oxidant that has irritant
properties.
Nasal Mucosa
The nasal mucosa has many components, all of which are
potentialtargetsforirritantexposure(2). Aprotein-richmucous
layerisgeneratedbysecretoryproductsfromsubmucosalglands
andsecretorycells, withwaterandsolutesprovidedbyepithelial
iontransport. Thenasalepitheliumattheentrancetothenoseis
astratifiedsquamousepithelium, butchangeswithinafewcen-
timeters topseudostratified ciliatedcolumnarepithelium. The
epithelium is composed ofciliated, secretory, and basal cells.
Situatedinthesubmucosaisacomplexvascularsupplythatcan
undergorapidchangesinbloodvolume. Sympathetic, parasym-
pathetic, and unmyelinated chemosensitive c-fiber neurons
ramifyextensivelythroughoutthemucosa, withprojectionsto
theepithelium, glands, andbloodvessels. Inflammatory cells,
includingneutrophils, eosinophils, basophilsandmastcells, and
mononuclearcellsmaybepresentontheairway surface, inthe
epithelium, orthe submocosa.
The irritant properties in indoor mixtures undoubtedly are
related in part to physicochemical properties ofthe individual
components. Mucosal irritationtestingusingtheDraizemethod
indicatesthatextremesofacidityandallinitypredictirritation.
However, asdemonstratedby thestudiesofMolhaveetal. (11)
andKorenetal. (12), exposuretovolatileorganicmixturesmay
also cause irritation, even though each individual component
doesnot. Speciesdifferencesintheresponsetoirritantsalsolimit
interpretationofanimal data. Forexample, amajordifference
betweenrodentsandhigherspeciesistheoccurrenceofedema
inthe former in responseto irritants (13).
Irritationisperceivedthroughstimulationofafferentneurons
that are part ofthe trigeminal nerve. Cain has emphasized in-
teractions between perceived odor and trigeminal stimulation
(14). The means by which afferent stimulation occurs is less
clear. Itmaybeadirectresultofnervefibersinteractingwiththe
chemical or an indirect result oflocally produced mediators.
Datapresentedbelow indicatethattheepitheliumandneurons
arekeytargetcellsthatamplifytheresponsetoirritantsthrough
the inductionofinflanmmation.
TobaccoSmoke
Achallengingscientificproblemofgreatpracticalimportance
in the work environment is the observeddifference in respon-
siveness toirritantmixturesinhumans. Thebiologicvariabili-
ty inresponsemaybeduetogeneticdifferences, environmental
factors, orboth. AcurrentfocusofinterestattheUniversityof
Maryland Environmental Research Facility is differential
40responsiveness toenvironmental tobacco smoke amonghealthy
youngadults. Thistopic waschosen forseveral reasons. Tobacco
smoke is an example ofa common indoorairpollutantand is a
complex mixture. Tobacco smoke is an exposurethat most in-
dividuals have encountered and recognize. People are usually
aware ofthe nature oftheir response to exposure. Healthy in-
dividuals with no illness or illness behavior report a range of
responses totobacco smoke. Furthermore, asdiscussedbelow,
animal studies suggest that the response to tobacco smoke is
modulatedthroughactivationofchemosensitive neurons. Anim-
provedunderstandingofthebasisfordifferential responsiveness
totobaccosmoke mayenhance ourunderstandingofthebasisfor
differential responsiveness toother irritants.
In our initial studies, aquestionnaire was administered to77
healthy nonsmoking youngadults who werebeingscreened for
participation in an unrelated study (16). Subjects were asked
whether they had a history of a group of symptoms associated
with environmental tobacco smoke exposure. Nearly 80%
reported ahistoryofeyeirritation, and morethan30% reported
one or more symptomofrhinitis (i.e., rhinorrhea, nasal conges-
tion, or sneezing). Nasal irritation was reported by 18%. This
survey was not apopulation-based study, so noprevalencedata
should be inferred. However, the study indicated that it was
possible to recruit subjects from thecommunity with differen-
tial historical responsiveness toenvironmental tobacco smoke.
We nextperformed controlled challenge studies comparing 11
environmental tobacco smoke-nonsensitive subjectsand 10 en-
vironmental tobacco smoke-sensitive subjects (15). Subjects
were exposed in aclimate-controlled facility to 15 minofclean
air followed by 15 min of a relatively high concentration of
sidestream tobacco smoke(45 ppmCO). Measuresofresponse
were symptoms, nasal resistance, and spirometry. On a second
study day theprotocol was repeated, and measures of response
were symptoms and nasal lavage mediators including histamine,
albumin, m-C-tosyl-L-arginine methyl ester (TAME)-esterase
activity, and kinnis.
Significantdifferences occurred between thehistorically sen-
sitive and nonsensitive subjects in the symptomatic and nasal
resistance response totobacco smoke challenge. Eye irritation,
nasal congestion, rhinorrhea, nose-throat irritation, chest
tightness, andcough wereall greater inthe historically sensitive
individuals. Odor perception was comparably elevated inboth
groups. Symptoms from the 2 study days were significantly cor-
related. The increase in nasal resistance after tobacco smoke
challenge was significantly greater intheenvironmental tobac-
co smoke-sensitive subjects compared with the environmental
tobacco smoke-nonsensitive subjects (Fig. 1) (15). Analysis of
proteins and mediators in nasal lavage fluid showed no signifi-
cant elevations of any ofthe three mediators or albumin. The
absenceofelevation inhistamine suggested thatthe response was
not an allergic, IgE-mediated response. The absence ofeleva-
tions ofalbumin, kinins, and TAME-esterase activity indicated
that increased vascularpermeability orglandular stimulation did
not account forthechanges innasal patency. The resultsindirect-
ly suggested that changes in vascular tone account for the
increased nasal resistance response totobacco smoke in the sen-
sitive subjects.
Earlierstudies oftobacco-smoke-related mucous membrane
presence ofsymptoms ofeye, nose, andthroatirritation occuring
at concentrations of environmental tobacco smoke as low as
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FIGURE 1. Nasal responseofenvironmental tobacco smoke (ETS)-sensitive
and environmental smoke-nonsensitive subjects after tobacco smoke
challenge (45 ppmCO for 15 min). (**)p < 0.01 smoke versusair; (++)p
< 0.01 ETS-sensitive versus ETS-nonsensitive subjects. Reproduced with
permission (i5).
presenceofsymptoms ofeye, nose, andthroatirritation occur-
ring atconcentrations ofenvironmental tobaccosmoke aslow as
1.3 and 2.5 ppmcarbonmonoxide (16). Time-response studies
showedthattherecognitionofodorreached aplateauduringthe
1-hr exposure, whileirritant symptomscontinuedtorise. Assess-
mentofairway inflammation was not partoftheir study.
Swedish investigators intheearly 1980s examinedthepossi-
ble contribution ofc-fiber neurons to the neuroinflammatory
response totobacco smoke(17-21). Intheirexperiments, guinea
pigs or rats wereexposed totobacco smoke, and inflammation
wasdemonstrated by a variety ofmeans includingcounting in-
creased nasalwipings andmeasuring increased EvansBluedye
extravasation (a measure ofincreased vascular permeability).
Filtrationofthetobacco smoke (whichremovedtheparticlesand
virtuallyallthenicotine)did notreducethe response. Pretreat-
mentoftheanimals with systemic, neonatal capsaicin blocked
the response to tobacco smoke, as did local anesthesia or sub-
stance Pantagonists. Thesedataindicatedthattheinflammatory
irritant response totobaccosmokeoccurredthroughstimulation
of c-fiber neurons by the organic, vapor-phase component of
tobacco smokeandthatreleaseoftheneuropeptide substance P
was part ofthe response.
Toaddressthepossibilitythatalteredtobaccosmoke respon-
siveness reflected differential function ofc-fiber neurons, our
study subjects werechallengedwith alowconcentrationofcap-
saicin. Historically environmentaltobaccosmoke-sensitive sub-
jects reported significantly more rhinorrhea following capsaicin
challenge compared with environmental tobacco smoke-non-
sensitive subjects (22).
Animal studies by Dusser et al. indicate that the respiratory
epithelium isboth a targetofirritant exposures and amodulator
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ofirritantresponse(23). Theseinvestigatorsmeasuredtheeffect
of aerosolized substance P on guinea pig airway resistance.
Underbaselineconditions, substance Phad littleeffect onair-
way tone. Followingexposuretocigarette smoke, however, the
increase in airways resistance to substance P challenge was
markedly augmented. This effect was subsequently demon-
stratedtobeassociatedwithadecreaseinneutralendopeptidase
intheairwayepitheliumandtobereversiblebytheadministra-
tionoftheantioxidantenzymesuperoxidedismutase(23). The
significance of this finding is that it suggests a possible non-
specific, nonimmunologicamplificationmechanismforirritants.
Simplyput, irritantsmaystimulatec-fiberneurons, causingthe
release of biologically active neuropeptides. They may
simultaneously decrease the presence of epithelial products
whosefunctionistoinactivatetheneuropeptides. Subsequentex-
posurestoirritantsmay resultinanetincrease inneuropeptide
release andnetincrease ininflammation, perhapsculminating
inend-organdamage. Furtherstudiesareneededtodetermine
whetherotherirritants orvolatile organic compound mixtures
will amplify the responseto substance P.
In vitrodataindicatethattherespiratory epithelium isbotha
target organ and an active respondent to irritants. Leikauf
demonstratedthatozoneinducedanaugmentAtionofeicosanoid
metabolism inbovinetrachealepithelialcells (24). Productsthat
werereleasedincludedprostaglandin E2(PGE2), prostaglandin
F2, (PGF2a), 6-keto-PGFia, andleukotrieneB4. Theincrease in
PGF2a began as low as 0.1 ppm ozone, a concentration that
occurseachsummerinmostmajorAmericancities. Releaseof
epithelial-derived eicosanoids was also demonstrated by
Doupnik etal. following in vitroexposure toacrolein (25).
Acrolein and Ozone
Animal exposure studies have demonstrated that both alde-
hydesandoxidantscausebronchial hyperresponsivenessandin-
flammation. Although thesearelowerrespiratory effects, they
areimportantdemonstrationsofpotentialeffectsofirritants on
mucosal surfaces. Withacrolein, exposureofguineapigs for2
hr to 0.3 to 1.26 ppm resulted in an immediate increase in
pulmonaryresistanceand2-to3-foldincreasesinthromboxane
B2andPGF2.immediately afterexposure. Tlwoto6hrafterex-
posuretherewas a3-foldincrease incholinergic hyperrespon-
siveness, while lavageneutrophils increased 5-fold24hrlater.
Human exposure studies have shown upper respiratory
mucosal inflammation after controlled challenge with ozone.
Graham et al. (26) showed a neutrophil influx after ozone
challenge inhealthy, normalsubjects, andBascometal. showed
amixedinflanunatorycellinfluxandanincreaseinnasallavage
albuminafterozonechallengeinasymptomaticallergicsubjects
(27). Thesubjects reportedmildnasal irritation atthetimethe
inflammation was observed. Gerrity et al. (28) showed that a
significant proportion of ozone was removed by the upper
respiratory tractofhumans, andanimal studiesbyHarkemaet
al. showedthattheupperrespiratory tractisanozonetarget(29).
When mucous membrane irritationcomplaintsoccurinrela-
tiontobuildingenvironments, thereisusuallyanabsenceofab-
normalitiesonroutinephysicalexaminationandlaboratorytests
(5). ButasKreisshaspointedout"thisgeneralizationreflectsthe
conclusionsofnonspecialistphysicianswithatypicaldiagnostic
armamentarium" (5). Objective evidence ofaltered mucosal
functionhasbeendemonstratedfortheeyes, wherecomplaints
ofeyeirritationhavebeenassociatedwithanabsenceoffoamin
theeyecanthus, decreasedstabilityofprecornealtearfilm, and
epithelial damagedocumentedby slitlamptechniques (30).
Fewhumanexposurestudieshaveassessedthehealtheffects
ofinhaledmixturesonnasalphysiology, anatomy, andbiology.
However, msearchmethodsforthestudyoftheupperrespiratory
tracthaveexpandedtremendouslyinrecentyears. Techniquesof
nasalchallengeandanalysisofcellsandmediatorsinnasallavage
fluidhaveprovedusefulinassessingrhinitiscausedbyantigens,
coldair, andviruses (31-34). Asdescribedabove, measurement
ofnasal resistancehasbeenusedto demonstrate aspectrumof
sensitivity to environmental tobacco smoke (16). Changes in
nonspecific nasal reactivity can bedemonstratedafterantigen
challenge(35). Othertechniquesavailableforindoorairresearch
include assessing trigeminal sensitivity, ciliary transport, and
epithelial permeability (2). After development in controlled
challenges, it is possiblethat someofthese techniques will be
useful for field studies, where the health effects ofa complex
mixture are being assessed ina specific indoorenvironment.
New research methods are needed, particularly to evaluate
complaints ofnasal drying and irritation. One promising ap-
proach isthatdescribedbyBaroody etal. in whichfilterpaper
discs areappliedtonasal septumandtheweightofairway sur-
face fluid determined (36). Using this approach, investigators
demonstratedareductioninairway surfacefluidinnonallergic
subjects24hrafterozoneexposure(0.4ppm, 2hr, intermittent
exercise) (36). Acoustic rhinometry may prove to be a useful,
effort-independent testto assess changes in theanatomy ofthe
upperairway (37). Currently, nasal rhinomanometry provides
only modest correlations with symptoms ofnasal congestion
(38), andrhinomanometrycanbedifficultforuntrainedsubjects
toperform.
There exists a group ofindividuals who report a variety of
symptomsonexposuretolowlevelsofcommonvolatileorganic
mixtures such as perfume, cigarette smoke, and soappowders
(39). Some ofthese individuals report having occupied "sick
buildings" duringthetimetheirsymptomsbegan. Studieshave
demonstratednoalterationintheirolfactorythreshold, andthere
is little evidence that an IgE mechanism is responsible for the
hyperresponsiveness. Otherhypothesized mechanisms include
a conditioned response to odors (40) and an alteration in
trigeminal sensitivity. Criticshavebeenquicktopointoutthat
theseindividualshave "soft" symptoms, meaningthattheycan-
not be validated by objective measures. This is largely true,
although many have recognizable diseases such as asthma or
vasomotorrhinitis. Additionalresearchisneededtounderstand
thebasis ofthesecomplaints, theiretiology, and treatment.
Research Needs
Theresearchneedspresentedbelowareorganizedbythebroad
hypothesis tobetested. There is acontinuing need for testable
hypotheses and improved methodology.
1. Differentialresponsivenesstoirritantmixturesisacom-
mon feature ofnormal healthy populations. Approach:
Epidemiologicalstudies: profileresponsivenesstoirritant
mixtures inaworkingpopulation (e.g., officebuilding).
Ask whether individuals responding affirmatively are
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"especially sensitive" totypical irritantmixtures. Deter-
minethefrequencyofindividuals respondingaffirmative-
ly to the question, their population distribution, and the
health symptoms they report.
2. Responsiveness to irritant mixtures is an inherited cha-
racteristic. Approach: Human challenge studies:
controlled challenges to establish whether adistribution
ofresponsivenessexists. Animalstudies: challenge studies
using inbred strainsofmicetodeterminewhetherspecific
physiologic orinflammatory reponseshaveageneticbasis.
Humanchallenge studies: twin studies (monozygotic ver-
susdizygotic) todeterminewhetherresponsesobservedin
animals are similarly determined inhumans.
3. Responsivenesstocommonirritantmixturesmaybemodi-
fiedbythepresenceofcommonlyoccurring, preexisting
disease. Approach: Humanstudies: controlledchallenges
comparing the response ofnormal individuals to the re-
sponse of individuals with allergic rhinitis, vasomotor
rhinitis, oratrophic rhinitis. Epidemiologic studies: com-
pare rates ofresponsiveness between normal people and
definedpatientgroupsincludinggroupswithandwithout
known mucosal disease (e.g., allergic rhinitis patients
compared to those with hypertension).
4. Low-level irritantmixtures will induceairwayinflamma-
tion. Approach: Animal studies: compare the responses
torepresentative mixtures (e.g., petroleumproducts, new
furnishings, household products, etc.). Human studies:
select mixtures andend pointsbased on animal data.
5. Increased historical responsiveness ispredictive ofanal-
tered inflammatory response. Approach: Human studies:
controlled challenge studies, assessing inflammation at
mucosal surfaces.
6. In vitro studies may predictthe irritantpotential ofVOC
mixtures. Approach: In vitro: screen avarietyofvolatile
organiccompound mixtures usingepithelial cellsorfibro-
blasts as target cells and a range of end points (e.g.,
mediatorrelease,detachment, colony-formingefficiency).
Correlate the in vitro data with human challenges or
animal challenges.
7. Irritant mixtures augment the response to substance P
throughthedepletionofepithelial neutralendopeptidase.
Approach: In vitro: screenavarietyofirritantsandvolatile
organic compoundmixtures fortheireffectsonepithelial
neutral endopeptidase. Takerepresentative examples and
correlatewith animal studies [see Dusser etal. (23)].
8. Multiplechemical sensitivity is asyndromethatisassoci-
ated withdistinct clinical features. Approach: Epidemi-
ology: establish acaseregistry using standard survey in-
struments. Comparefeaturesofindexcaseswithacontrol
group from the same clinic. Case evaluation: perform
carefulclinical evaluationsofindividuals comparing their
health statuswhenincontactandremovefromsymptom-
causing exposures.
9. Populations withsymptomsofsickbuildingsyndromewill
demonstrateincreasedmucosal inflammationcompared
with less symptomatic populations. Approach: Bio-epi-
demiology: Perform nasal lavages orobtain nasal scrap-
ings from populations with differential rates of airway
symptoms. Compare the degree ofvascular leak (nasal
lavage albumin), cellular inflammation (percent neutro-
phils), andsquamousmetaplasia(cytologicexamination).
Analyzeepithelial cellsviainsituhybridization foraltered
expressionofprecursors forinflammatory mediatorssuch
a cytokines.
In addition to studies such as those described above, basic
research on the biology ofthe airway epithelium is critically
important. Research intheseareaswillelucidatethemediators
andotherproductsofthesecells. Researchwilldemonstratehow
altered morphology (as is seen with chronic irritantexposure)
alters the response to irritants. Research in these areas will
doubtless provide rich ground for increasingly focused
hypotheses ontheeffectsofirritantmixtures onhumanhealth.
Considerable effort has been expended on human studies
assessingthehealtheffectsofexposuretoozone. Thesestudies
should beextendedto furtherdefine the tissue targetsofozone
andthealterationsincellbiologythatoccurwithozoneexposure.
Furthermore, thebasis fordifferentialresponsiveness toozone
shouldbeexplored. Theresultsoftheseinvestigations willpro-
videvaluableinsights asadditional studiesontheeffectsofirri-
tant mixtures aredesigned.
The authors gratefully acknowledge theassistance ofThomas K. Fitzgerald
and Larry Sauder and the collaboration ofThomas Kulle, Anne K. Sobotka,
and David Proud. The author's research was funded by the American Lung
Association, National InstitutesofHealth, the Center forIndoorAirResearch,
and the University of Maryland School of Medicine Designated Research
Initiative Fund.
RE:FERENCES
1. World HealthOrganization. IndoorAirQuality Research: ReportonaWHO
Meeting, Vol. 2. WHO, Geneva, 1986, p. 103.
2. Proctor, D. F., andAnderson, I. B. TheNose, UpperAirPhysiologyandthe
Atmospheric Environment. ElseierBiomedical, New York, 1982.
3. Hallenbeck, W H., andCunningham, K. M. QuantitativeRiskAssessment
for Environmental and Occupational Health. Lewis Publishers, Inc.,
Chelsea, MI, 1986.
4. Bascom, R., Proud, D., Togias, A. G., Peters, S. P., Norman, P. S., Kagey-
Sobotka, A., Lichtenstein, L. M., andNaclerio, R. M. Nasalprovocation:
anapproachtostudythemediatorsofallergicandnon-allergic rhinitis. In:
ProceedingsoftheXllthInternationalCongressofAllergyandClinical Im-
munology, Washington, DC, 1986. The C.V. Mosby Company, St. Louis,
MO, 1986, pp. 113-120.
5. Kreiss, K. Theepidemiology ofbuilding-related complaintsandillness. State
Art Rev. Occup. Med. 4: 575-592 (1989).
6. Environmental ProtectionAgency. IndoorAirQuality andWork Environ-
ment Study: EPA Headquarters' Buildings, Vol. 1, Employee survey.
19K-1003:ES-l-C-54, EPA, Washington, DC, 1989.
7. Samet, J. M., Marbury, M. C.,andSpengler, J. D. Healtheffectsandsources
ofindoor airpollution, Parts 1 and 2. Am. Rev. Respir. Dis. 137: 221-242
(1988).
8. Finnegan, M.J., Pickering, C. A. C., andBurge, P. S. Thesickbuilding syn-
drome: prevalence studies. Br. Med. J. 289: 1573-1575 (1984).
9. Burge, S., Hedge, A.,Wilson, S.,andAl, E. Sickbuildingsyndrome: astudy
of4373 officewvrkers. Ann. Occup. Hyg. 31: 493-504 (1987).
10. Skov, P., andValbjorn,Q. DanishIndoorClimateStudyGroup. The "sick"
building syndrome in the office environment. Environ. Int. 13: 339-349
(1987).
11. Molhave, L., Bach, B., and Pedersen, 0. F. Human reactionsduring con-
trolledexposurestolowconcentrationsoforganicgasesandvapoursknown
asnormal indoorairpollutants. In: IndoorAir: Proceedingsofthe3rdIn-
ternational Conference on Indoor Air Quality and Climate, Stockholm,
Sweden. (B. Berglund, T. Lindvall, andJ. Sundell, Eds.), SwedishCoun-
cil forBuilding Research, Stockholm, 1984, pp. 431-436.44 R. BASCOM
12. Koren, H. S., Graham, D. E., Steingold, S., and Devlin, R. The inflam-
matory responseofthehuman upperairwaystovolatileorganiccompounds
(VOC). Am. Rev. Respir. Dis. 141: A426 (1990).
13. Lundberg, J. M., Lundblad, L., Martling, C. R., Saria, A., Sjarne, P., and
Anggard, A. Coexistenceofmultiplepeptidesandclassictransmitters inair-
way neurons: functional andpathophysiologicaspects. Am. Rev. Respir. Dis.
136: S16-S22 (1987).
14. Cain, W. S. Contribution ofthe trigeminal nerve to perceived odor mag-
nitude. Ann. N.Y. Acad. Sci. 237: 28-34(1974).
15. Bascom, R., Kulle, T., Kagey-Sobotka, A., andProud, D. Upperrespiratory
tractenvironmental tobacco smokesensitivity. Am. Rev. Respir. Dis. 143:
1304-1311 (1991).
16. Muramatsu, T., Weber, A., Muramatsu, S., and Akermann, F. An ex-
perimental study on irritation andannoyancedue topassive smoking. Int.
Arch. Occup. Environ. Health. 51: 305-317 (1983).
17. Lundberg, J. M., Martling, C.-R., andSaria, A. Substance Pandcapsaicin-
induced contraction ofhuman bronchi. Acta. Physiol. Scand. 119: 49-53
(1983).
18. Lundberg, J. M., Lundblad, L., Saria, A., and Anggard, A. Inhibition of
cigarettesmokeinducedoedemainthenasalmucosabycapsaicinpretreat-
mentandasubstancePantagonist. Naunyn-Schmiedeberg Arch. Pharmacol.
326: 181-185 (1984).
19. Lundberg, J. M., and Saria, A. Capsaicin-induceddesensitization ofairway
mucosatocigarette smoke, mechanical andchemical irritants. Nature 302:
251-253 (1983).
20. Lundblad, L., and Lundberg, J. M. Capsaicin sensitive sensory neurons
mediate the response to nasal irritation induced by the vapour phase of
cigarette smoke. Toxicology 33: 1-7 (1984).
21. Lundblad, L., Lundberg, J. M., andanggard, A. Local andsystemic cap-
saicin pretreatment inhibits sneezing and the increase in nasal vascular
permeability induced by certain chemical irritants. Naunyn-Schmiedeberg
Arch. Pharmacol. 326: 254-261 (1984).
22. Bascom, R., Kagey-Sobotka, A., and Proud, D. Effect ofintranasal cap-
saicin on symptoms and mediator release. J. Pharmacol. Exp. Ther., in
press.
23. Dusser, D. J., Djokic, T. D., Borson, D. B.,andNadel, J. A. Cigarette smoke
induces bronchoconstrictor hyperresponsiveness to substance P and inac-
tivatesairway neutralendopeptidase intheguineapig. Pbssibleroleoffree
radicals. J. Clin. Invest. 84: 900-906 (1989).
24. Leikauf,G. D.,Driscoll, K. E.,andWey, H. E.Ozone-inducedaugmentation
ofeicosanoid metabolism inepithelial cells frombovinetrachea. Am. Rev.
Respir. Dis. 137: 435-442 (1988).
25. Doupnik, C. A., andLeikauf, G. D. Acroleinstimulateseicosanoid release
from bovine airway epithelial cells. Am. J. Physiol. 259: L222-229
(1990).
26. Graham, D., Henderson, F., andHouse, D. Neutrophil influx measuredin
nasal lavages of humans exposed to ozone. Arch. Environ. Health 43:
228-233 (1988).
27. Bascom, R., Naclerio, R. M., Fitzgerald, T. K., Kagey-Sobotka, A., and
Proud, D. Effectofozoneontheresponsetonasal challengewithantigenof
allergic subjects. Am. Rev. Respir. Dis. 142:594-601 (1990).
28. Gerrity, T. R., Weaver, R. A., Berntsen, J., House, D. E., andO'Neil,J. J.
Extrathoracic and intrathoracic removal of03 intidal-breathing humans. J.
Appl. Physiol. 65: 393-400 (1988).
29. Harkema, J. R., Plopper, C. G., Hyde, D. M., George, J. A. S., Wilson, D.
W, andDungworth, D. L. Responseofthemacaquenasalepitheliumtoam-
bient levels ofozone. Am. J. Pathol. 128: 29-44 (1987).
30. Franck, C. Eye symptoms and signs inbuildings with indoor climate pro-
blems ("office eye syndrome"). Acta Ophthalmol. 64: 306-311 (1986).
31. Creticos, P. S., Peters, S. P.,Adkinson, N. F.,Jr., Naclerio, R. M., Hayes,
E. C., Norman, P. S., andLichtenstein, L. M. Peptideleukotriene release
after antigen challenge in patients sensitive to ragweed. N. Engl. J. Med.
310:1626-1630 (1984).
32. Naclerio, R. M., Proud, D., Lichtenstein, L. M., Kagey-Sobotka, A.,
Hendley, J. G, Sorrentino, J., andGwaltney, J. M. Kininsaregenerateddur-
ing experimental rhinovirus colds. J. Infect. Dis. 157: 133-142 (1988).
33. Togias, A. G., Naclerio, R. M., Proud, D., Fish, J. E., Adkinson, N. F., Jr.,
Kagey-Sobotka, A., Norman, P. S., andLichtenstein, L. M. Nasalchallenge
withcold,dryairresultsinreleaseofinflammatory mediators: possiblemast
cell involvement. J. Clin. Invest. 76: 1375-1381 (1985).
34. Naclerio, R. M., Proud, D. Togias, A. G., Adkinson, N. F.,Jr., Meyers, D.
A., Kagey-Sobotka, A., Plaut, M., Norman, P. S., andLichtenstein, L. M.
Inflammatory mediators inlateantigen-induced rhinitis. N. Engl. J. Med.
313: 65-70 (1985).
35. Walden, S., Proud, D., Lichtenstein, L. M., Kagey-Sobotka, A., Norman,
P. S., andNaclerio, R. M. Nasal challenge withantigen leads to increased
sensitivity tohistamine(abstract). J. AllergyClin. Immunol. 81: 282 (1988).
36. Baroody, F., Raford, P., Willes, S., Fitzgerald, T. K., Naclerio, R. M., and
Bascom, R. Theeffectofozoneonthenasal response tomethacholine (mc)
inallergic andnonallergic subjects. Am. Rev. Respir. Dis. 143: A93 (1991).
37. Hilberg, O., Jackson, A. C., Swift, D. L., and Pederson, Q. F. Acoustic
rhinometry: evaluation ofnasal cavity geometry by acoustic reflection. J.
Appl. Physiol. 66: 295-303 (1989).
38. Cole, P. Upperrespiratoryairflow. In: TheNose, UpperAirPhysiology and
the Atmospheric Environment (D. F. Proctor and I. B. Anderson, Eds.),
ElsevierBiomedical, New York, 1982, pp. 163-182.
39. Cullen, M. R., Ed. WbrkerswithMultipleChemical Sensitivities. StateArt
Rev. Occup. Med. 2(4) (1987).
40. Bolla-Wilson, K., Wilson, R.J., andBleeker, M. L. Conditioningofphysical
symptomsafterneurotoxic exposure. J. Occup. Med. 30: 684-686(1988).